Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents and Available-For-Sale Securities (Details)

Cash, Cash Equivalents and Available-For-Sale Securities (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Cash, cash equivalents and available-for-sale securities
Cash and cash equivalents	$ 12,814	$ 20,854	$ 16,031	$ 33,484
Available-for-sale securities	144,858	191,121
Cash, cash equivalents and available-for-sale securities	157,672	211,975
Money Market Funds [Member]
Cash, cash equivalents and available-for-sale securities
Cash, cash equivalents and available-for-sale securities	8,754	9,059
U S Treasury Securities [Member]
Cash, cash equivalents and available-for-sale securities
Investments at fair value	2,029	2,085
U S Government Sponsored Enterprises Debt Securities [Member]
Cash, cash equivalents and available-for-sale securities
Investments at fair value	52,093	67,178
Corporate Bond Securities And Commercial Paper [Member]
Cash, cash equivalents and available-for-sale securities
Investments at fair value	94,036	133,458
Demand Deposits [Member]
Cash, cash equivalents and available-for-sale securities
Cash, cash equivalents and available-for-sale securities	$ 760	$ 195

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References + Details